Ireland
--:--IST
Latest
Clinical Trials in Switzerland / NCT03837158
Active, not recruiting Not applicable

Titanium Zirconium (TiZr) Mini Implants

NCT03837158 · tracked via the Priya Life Science Switzerland tracker
Phase
Not applicable
Started
2019-09-01
Last updated
2026-02-18

Condition(s) studied

Dental Implants

Investigational drug(s) / intervention(s)

early loadingimmediate loading

early loading: two TiZr implants on SLA surface

immediate loading: four TiZr implants on SLA surface

Study summary

H0: "Within the first year post-placement, four interforaminally placed, immediately loaded 2.4 mm narrow-diameter one-piece TiZr implants with miniaturized stud-type attachments show improved patient-reported outcome measures (PROMS) compared to two interforaminally placed, early loaded, TiZr two-piece implants with stud-type attachments to retain a mandibular overdenture."The specific aim is to compare both treatment alternatives to evaluate which one may be recommended for elderly edentulous patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * At patient level: * Written informed consent * Age ≥ 18 years * Sufficient complete dentures (Marxkors and Ferger, 1989) not older than 1 year * Patient is unsatisfied with mandibular denture to the degree that he/she seeks treatment * At site level: * Healed edentulous mandible (minimum 8 weeks since last extraction) * Minimal ridge dimensions 5.5 mm (width) by 12 mm (height) in the anterior (interforaminal) area, allowing the placement of 3.3 (endosseous diameter) by 10 mm (length) implants * Opposing dentition: complete denture on a edentulous maxilla * Physical status (PS) 1 and 2 (American Society of Anesthesiologists) Exclusion Criteria: * At patient level * Any physical or mental disorder that would interfere with the ability to perform adequate oral hygiene or the capability of providing written informed consent and compliance to the protocol * Any disorder that would interfere with wound healing or represent a contraindication for oral surgery such as, but not limited to, uncontrolled diabetes or conditions resulting in or requiring immunosuppression, radiation, chemotherapy, frequent use of antibiotics or antiresorptive medication such as bisphosphonates * Pregnancy or lactation * Heavy smoking habit with \> 20 cig/d * Severe bruxism or clenching habits, present oro-facial pain * At site level: * Ridge defects requiring staged bone augmentation procedures (simultaneous Guided Bone Regeneration (GBR) within the ridge contour allowed)

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Private Practice Dr. B. Wallkamm Langenthal Canton of Bern
University of Bern Bern Switzerland

More University of Bern trials in Switzerland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03837158 on ClinicalTrials.gov ↗ ← All trials in Switzerland